News Daily News Outcomes Suffer When Device-Related Thrombus Persists or Recurs After LAAO Todd Neale November 29, 2023
News Conference News AHA 2023 ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF Todd Neale November 12, 2023
News Conference News TCT 2023 Watchman, Amulet LAAO Devices Have Similar Leak Rates at About 1 Year Todd Neale October 25, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Conference News ESC 2023 NOAH-AFNET 6: Edoxaban for Atrial High-Rate Episodes: No Help, Some Harm Todd Neale August 25, 2023
News Conference News EuroPCR 2023 AnchorMan LAAO Device Matches Up Well With the Watchman Todd Neale May 19, 2023
News Daily News NT-proBNP May Help Hone AF Screening With Implantable Loop Recorder Todd Neale April 21, 2023
News Daily News LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis Todd Neale February 24, 2023
News Conference News ISC 2023 Does All AF After Stroke Warrant Anticoagulation? Experts Debate Todd Neale February 17, 2023
News Daily News Intracardiac Echo a Good Imaging Option to Guide LAA Closure Michael O'Riordan February 10, 2023
News Conference News ISC 2023 Continuous Monitoring Finds AF Up to 3 Years After Noncryptogenic Stroke Todd Neale February 08, 2023
News Daily News Slight Risk of Interstitial Lung Disease Seen With Certain DOACs Todd Neale November 23, 2022
News Daily News Apixaban Again Linked to Less Bleeding in AF Patients Michael O'Riordan October 31, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022